{
    "organizations": [],
    "uuid": "e0fc022c51e58b3f192bc10e99bb70a26a1f72d6",
    "author": "cnbc.com",
    "url": "https://www.cnbc.com/2018/02/06/the-associated-press-gilead-reports-4q-loss.html",
    "ord_in_thread": 0,
    "title": "Gilead reports 4Q loss",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "FOSTER CITY, Calif. (AP) _ Gilead Sciences Inc. (GILD) on Tuesday reported a fourth-quarter loss of $3.87 billion, after reporting a profit in the same period a year earlier.\nThe Foster City, California-based company said it had a loss of $2.96 per share. Earnings, adjusted for one-time gains and costs, came to $1.78 per share.\nThe results topped Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.70 per share.\nThe HIV and hepatitis C drugmaker posted revenue of $5.95 billion in the period, which also topped Street forecasts. Eight analysts surveyed by Zacks expected $5.78 billion.\nGilead expects full-year earnings in the range of $1.41 to $1.51 per share.\nGilead shares have risen 12 percent since the beginning of the year, while the Standard & Poor's 500 index has climbed almost 1 percent. In the final minutes of trading on Tuesday, shares hit $80.38, a rise of 11 percent in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD",
    "published": "2018-02-06T23:45:00.000+02:00",
    "crawled": "2018-02-07T01:52:03.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "foster",
        "city",
        "ap",
        "gilead",
        "science",
        "gild",
        "tuesday",
        "reported",
        "loss",
        "billion",
        "reporting",
        "profit",
        "period",
        "year",
        "earlier",
        "foster",
        "city",
        "company",
        "said",
        "loss",
        "per",
        "share",
        "earnings",
        "adjusted",
        "gain",
        "cost",
        "came",
        "per",
        "share",
        "result",
        "topped",
        "wall",
        "street",
        "expectation",
        "average",
        "estimate",
        "analyst",
        "surveyed",
        "zacks",
        "investment",
        "research",
        "earnings",
        "per",
        "share",
        "hiv",
        "hepatitis",
        "c",
        "drugmaker",
        "posted",
        "revenue",
        "billion",
        "period",
        "also",
        "topped",
        "street",
        "forecast",
        "eight",
        "analyst",
        "surveyed",
        "zacks",
        "expected",
        "billion",
        "gilead",
        "expects",
        "earnings",
        "range",
        "per",
        "share",
        "gilead",
        "share",
        "risen",
        "percent",
        "since",
        "beginning",
        "year",
        "standard",
        "poor",
        "index",
        "climbed",
        "almost",
        "percent",
        "final",
        "minute",
        "trading",
        "tuesday",
        "share",
        "hit",
        "rise",
        "percent",
        "last",
        "month",
        "story",
        "generated",
        "automated",
        "insight",
        "http",
        "using",
        "data",
        "zacks",
        "investment",
        "research",
        "access",
        "zacks",
        "stock",
        "report",
        "gild",
        "http"
    ]
}